The NIHR Invention for Innovation (i4i) Programme has launched the 19th round of its i4i Product Development Awards (PDAs) today.
The awards support medical technology innovations at any stage of translational research and development pathways, including clinical evaluation, with the overall aim of de-risking projects for further investment. The projects have no upper funding limit and can be up to 36 months in duration.
Questions? Please join one of two live FAQ sessions on either the 11th or 15th November, where members of the i4i team will be on-hand to answer your queries.